Callio Therapeutics Launches with US$187 Million Series A to Advance Multi-Payload Antibody-Drug Conjugate Platform Through Clinical Proof-of-Concept Frazier Life Sciences launches Callio Therapeutics based on multi-payload antibody-drug conjugate technology… CISION PRNewswireMarch 3, 2025
Moldova e-Governance Agency Joins EU Digital Identity Wallet Pilot CHIȘINĂU, Moldova, March 3, 2025 /PRNewswire/ — The e-Governance Agency of Moldova (AGE)… CISION PRNewswireMarch 3, 2025
Press ReleaseNYSE CONTENT ADVISORY: PRE-MARKET UPDATE FOR MARCH 3RD NEW YORK, March 3, 2025 /PRNewswire/ — The New York Stock Exchange… CISION PRNewswireMarch 3, 2025
Press ReleaseBruno Marc Redefines Men's Oxford Shoes for Spring 2025 Distinct Designs for Every Defining Moment — From Office to Weekend NEW… CISION PRNewswireMarch 3, 2025
Tantech Holdings Regains Compliance with NASDAQ Minimum Bid Price Requirement LISHUI, China, March 3, 2025 /PRNewswire/ — Tantech Holdings Ltd (NASDAQ: TANH)… CISION PRNewswireMarch 3, 2025
Press ReleaseBybit Report: Gold Set to Surpass $3,000 in 2025 DUBAI, UAE, March 3, 2025 /PRNewswire/ — Bybit, the world’s second-largest cryptocurrency exchange… CISION PRNewswireMarch 3, 2025
Press ReleaseHONOR Announces 7 Years of Android OS and Security Updates for the HONOR Magic Series Extended support allows flagship devices to maintain access to the latest AI… CISION PRNewswireMarch 3, 2025
Acurx Announces Publication of Nonclinical In Vivo Data Differentiating Ibezapolstat's Gut Microbiome Effects from Other Anti-CDI Antibiotics First ever head-to-head comparison of gut microbiome changes associated with ibezapolstat (IBZ)… CISION PRNewswireMarch 3, 2025
